TradingKey - As IBM earnings approach, rising risk aversion puts pressure on the stock price, sending it down toward $240 with the risk of further sliding to the $200 level.
On October 21 Eastern Time, century-old tech giant IBM (IBM) fell slightly in pre-market trading, dipping back near $240 again. Does this mean the bottom-fishing rebound rally has ended?
Since peaking in June this year, IBM's stock price has steadily declined from its all-time high of $330 to a low near $200 at the end of July, resulting in a maximum drawdown of nearly 40%. Since then, IBM's stock has staged a rebound, but has consistently failed to break above $250.
The recent lack of momentum in IBM's stock price rebound is primarily due to the macroeconomic environment weighing on its business. Impacted by macro inflation and prolonged high interest rates, global enterprise clients have turned cautious regarding spending on non-core IT consulting and digital transformation projects. Market participants worry that Q3 consulting revenue growth could slow to single digits or even remain flat year-over-year, squeezing overall gross margin.
Although bookings for the IBM Watsonx AI platform continue to grow, whether Red Hat infrastructure revenue can sustain double-digit rapid growth remains to be tested. If AI tools fail to translate significantly into high-margin incremental subscriptions, quantitative funds may defensively de-rate its high valuation.
After the market closes today, IBM will report its third-quarter (Q3) 2026 financial results. If the reported figures fail to alleviate the market's aforementioned concerns or if guidance falls severely short of expectations, the stock price could drop another 16%, testing the $200 level directly. However, IBM possesses high free cash flow and solid dividend distribution capabilities, making a breakdown below $200 less likely; it is more of a chip shakeout stemming from a high valuation.
IBM stock price chart, Source: TradingView
If earnings per share (EPS) and free cash flow beat expectations, and management delivers strong full-year FCF guidance, the stock price will extend its rebound. However, the upside potential of IBM's rebound remains limited, facing a resistance zone of $248–$252, which represents the highest point of the recovery since the plunge in July this year. A direct breakthrough in the short term is unlikely unless macroeconomic policy shifts toward easing.